acetylcysteine has been researched along with Leigh Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, VE; Burg, L; Falk, MJ; Haroon, S; He, J; Kose, M; Mathew, ND; Nair, RM; Nakamaru-Ogiso, E; Osei-Frimpong, B; Seiler, C; Venkata, CRM; Yoon, H | 1 |
| Arisaka, A; Ichimoto, K; Kumada, S; Kuwajima, M; Murayama, K; Ogawa, E; Ohtake, A; Osaka, H; Sato-Shirai, I; Watanabe, M | 1 |
| Ganetzky, R; Loomes, KM; Monteil, D; Murali, CN; Padilla, CD; Scaglia, F; Shah, AA; Soler-Alfonso, C | 1 |
3 other study(ies) available for acetylcysteine and Leigh Disease
| Article | Year |
|---|---|
N-acetylcysteine and cysteamine bitartrate prevent azide-induced neuromuscular decompensation by restoring glutathione balance in two novel surf1-/- zebrafish deletion models of Leigh syndrome.
Topics: Acetylcysteine; Adult; Animals; Azides; Brain Death; Cysteamine; Cytochrome-c Oxidase Deficiency; Electron Transport Complex IV; Glutathione; Humans; Lactates; Leigh Disease; Membrane Proteins; Mitochondrial Proteins; Zebrafish | 2023 |
Valine-restricted diet for patients with ECHS1 deficiency: Divergent clinical outcomes in two Japanese siblings.
Topics: Acetylcysteine; Cysteamine; Diet Therapy; Enoyl-CoA Hydratase; Family; Female; Genetic Testing; Humans; Infant; Japan; Leigh Disease; Magnetic Resonance Imaging; Male; Mutation; Pedigree; Siblings; Treatment Outcome; Valine | 2021 |
TRMU deficiency: A broad clinical spectrum responsive to cysteine supplementation.
Topics: Acetylcysteine; Acidosis; Cysteine; DNA, Mitochondrial; Female; Humans; Infant; Leigh Disease; Liver Failure; Liver Transplantation; Male; Mitochondria; Mitochondrial Proteins; Protein Biosynthesis; RNA, Transfer; tRNA Methyltransferases | 2021 |